Helixgate

Helixgate

Uncategorized

Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipeline

Published

on

On Friday, Kailera Therapeutics raised a record-setting $625 million through an IPO on the Nasdaq. Founded with backing from Bain Capital Life Sciences, and a pipeline of obesity assets from China’s Hengrui …

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Three gene therapy pioneers just won the Breakthrough Prize. This is their story

Published

on

A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably one of the most prominent recognitions yet for the field …

Continue Reading

Uncategorized

How Trump is pushing psychedelics reform through the health agencies

Published

on

WASHINGTON — President Trump moved on Saturday to “reverse the crisis of serious mental illness in America” by boosting access to psychedelic drugs in clinical settings. In an executive order, he directed the federal government to rush access to treatments and reevaluate their status as controlled substances.

The order directs the Food and Drug Administration to expedite some psychedelics as breakthrough drugs, as well as allowing them to be used through right-to-try legislation, which allow terminally ill patients to try experimental drugs outside of usual regulatory pathways.

Read the rest…

Continue Reading

Uncategorized

Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role

The nomination of a new leader for the Centers for Disease Control and Prevention — one who has scientific credentials and no public ties to the anti-vaccine movement — has generated sighs of relief in the public health world. 

As one CDC employee, who asked not to be named, put it on Friday, among staff “the general vibe is guarded but hopeful.”

Read the rest…

Read More

Published

on

The nomination of a new leader for the Centers for Disease Control and Prevention — one who has scientific credentials and no public ties to the anti-vaccine movement — has generated sighs of relief in the public health world. 

As one CDC employee, who asked not to be named, put it on Friday, among staff “the general vibe is guarded but hopeful.”

Read the rest…

Read More

Continue Reading
Advertisement

Trending